CompletedPhase 2NCT02654509
Safety and Immunogenicity Study of the Eastern Equine Encephalitis (EEE) Vaccine
Studying Eastern equine encephalitis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- U.S. Army Medical Research and Development Command
- Principal Investigator
- Robert Rivard, MD, M.DUS Army Medical Research Institute of Infectious Diseases
- Intervention
- Eastern Equine Encephalitis Vaccine, Inactivated, Dried, TSI-GSD 104(biological)
- Enrollment
- 138 enrolled
- Eligibility
- 18-65 years · All sexes
- Timeline
- 2008 – 2018
Study locations (1)
- Special Immunizations Program, Division of Medicine, USAMRIID, Fort Deterick, Maryland, United States
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT02654509 on ClinicalTrials.gov